Reuters: Pay-to-play claims fuel rematch with pension fund over class action fees
Reuters covered HLLI's objection in "In re Mylan N.V. Securities Litigation".
HLLI Challenges $14.9 Million Fee Request in Class Action Lawsuit That Returns About a Penny on the Dollar to Class Members
The Hamilton Lincoln Law Institute’s Center for Class Action Fairness filed an objection to a fee request in a shareholder settlement over Mylan Pharmaceuticals stock.
In re Mylan N.V. Securities Litigation
HLLI's Center for Class Action Fairness and its director Ted Frank objected to a fee request in a shareholder settlement over Mylan Pharmaceuticals stock.
